+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Cardiac Disease Market Outlook to 2036 - Cardiac Marker Tests

  • PDF Icon

    Report

  • 124 Pages
  • May 2026
  • Region: North America
  • GlobalData
  • ID: 6115085

North America Cardiac Disease Market Outlook to 2036 - Cardiac Marker Tests

Summary

The analyst’s “North America Cardiac Disease Market Outlook to 2036” is a comprehensive databook report, covering key market data on the North America Cardiac Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Marker Tests

The North America Cardiac Disease Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
  • 2025 company share data for Cardiac Disease Market.
  • Global corporate-level profiles of key companies operating within the North America Cardiac Disease Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Cardiac Disease is segmented as follows:

  • Cardiac Marker Tests

Reasons to Buy

The North America Cardiac Disease Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

1 Introduction
1.1 What Is This Report About?
1.2 Cardiac Disease Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Cardiac Disease Market, North America
2.1 Cardiac Disease Market, North America, Revenue ($m), 2024-2036
2.2 Cardiac Disease Market, North America, Revenue ($m), 2024-2036
2.3 Cardiac Disease Market, North America, Volume (Units), 2024-2036
2.4 Cardiac Disease Market, North America, Volume (Units), 2024-2036
2.5 Cardiac Disease Market, North America, Company Share by Revenue ($m), 2025
3 Cardiac Disease Market, Canada
3.1 Cardiac Disease Market, Canada, Revenue ($m), 2024-2036
3.1.1 Cardiac Marker Tests Market, Canada, Revenue ($m), by Segment, 2024-2036
3.2 Cardiac Disease Market, Canada, Volume (Units), 2024-2036
3.2.1 Cardiac Marker Tests Market, Canada, Volume (Units), by Segment, 2024-2036
3.3 Cardiac Disease Market, Canada, Average Price ($), 2024-2036
3.4 Cardiac Disease Market, Canada, Company Share by Revenue ($m), 2025
4 Cardiac Disease Market, Mexico
4.1 Cardiac Disease Market, Mexico, Revenue ($m), 2024-2036
4.1.1 Cardiac Marker Tests Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.2 Cardiac Disease Market, Mexico, Volume (Units), 2024-2036
4.2.1 Cardiac Marker Tests Market, Mexico, Volume (Units), by Segment, 2024-2036
4.3 Cardiac Disease Market, Mexico, Average Price ($), 2024-2036
4.4 Cardiac Disease Market, Mexico, Company Share by Revenue ($m), 2025
5 Cardiac Disease Market, United States
5.1 Cardiac Disease Market, United States, Revenue ($m), 2024-2036
5.1.1 Cardiac Marker Tests Market, United States, Revenue ($m), by Segment, 2024-2036
5.2 Cardiac Disease Market, United States, Volume (Units), 2024-2036
5.2.1 Cardiac Marker Tests Market, United States, Volume (Units), by Segment, 2024-2036
5.3 Cardiac Disease Market, United States, Average Price ($), 2024-2036
5.4 Cardiac Disease Market, United States, Company Share by Revenue ($m), 2025
6 Cardiac Disease Market Pipeline Products
6.1 Cardiac Disease Market Pipeline Products
6.2 Cardiac Disease - Pipeline Products by Stage of Development
6.3 Cardiac Disease - Pipeline Products by Segment
6.4 Cardiac Disease - Pipeline Products by Territory
6.5 Cardiac Disease - Pipeline Products by Regulatory Path
6.6 Cardiac Disease - Pipeline Products by Estimated Approval Date
7 Overview of Key Companies in North America Cardiac Disease Market
7.1 F. Hoffmann-La Roche Ltd
7.1.1 Company Overview
7.2 Abbott Laboratories
7.2.1 Company Overview
7.3 Beckman Coulter Inc
7.3.1 Company Overview
7.4 Quidel Corp
7.4.1 Company Overview
7.5 Siemens Healthineers AG
7.5.1 Company Overview
7.6 bioMerieux SA
7.6.1 Company Overview
8 Recent Developments
8.1 Corporate Communications
8.1.1 Feb 09, 2026: Humacyte Announces New u.s. Department of Defense Funding for Procurement of Bioengineered Blood Vessels
8.1.2 Jan 27, 2026: Johnson & Johnson Marks $100 Million of Medtech Products Donated Since 2020 To Help People Live, See and Smile
8.1.3 Oct 02, 2025: Dyne Therapeutics Appoints Brian Posner to Its Board of Directors
8.2 Financial Announcements
8.2.1 Apr 15, 2026: Cosmos Health Reports Full Year 2025 Results
8.2.2 Feb 18, 2026: Cardio Diagnostics Holdings to Host Investor Call on Thursday, February 19, 2026
8.3 Government and Public Interest
8.3.1 Nov 03, 2025: Dyne Therapeutics to Present at Upcoming Investor Conferences
8.4 Legal And Regulatory
8.4.1 Sep 02, 2025: Innovative Health Prevails in Lawsuit Against J&J's Biosense Webster for Restraint of Trade
8.5 Other Significant Developments
8.5.1 Feb 18, 2026: Maestro MEA Platform Powers First Stem Cell Cardiac Safety Assay in FDA ISTAND Program
8.5.2 Nov 24, 2025: AI/ML Subsidiary Neural Cloud Begins Pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care
8.6 Product News
8.6.1 May 11, 2026: Heart scan and blood test improve risk prediction for inherited heart condition, major study finds
8.6.2 Apr 30, 2026: Medical Component Specialists to Support Catheter R&D Masterclass in Ireland
8.6.3 Mar 12, 2026: PsyMetRiC: Tool to Predict Physical Health Risks in Young People With Psychosis
8.6.4 Mar 10, 2026: New AI Solution Helps Predict Which Lung Cancer Patients Will Benefit from Immunotherapy
8.6.5 Feb 12, 2026: HRS Releases Scientific Statement on Pulsed Field Ablation for Cardiac Arrhythmias
8.6.6 Oct 27, 2025: University of Alberta: Some Cancer Patients Get Heart Damage During Chemotherapy and Some Don’t
8.6.7 Oct 21, 2025: PET Imaging of Inflammation Predicts Recovery, Guides Therapy After Heart Attack
8.6.8 Oct 06, 2025: New Calculator to Better Predict Stroke Risk in Atrial Fibrillation Patients
8.6.9 Sep 17, 2025: AI Outperforms Doctors In Predicting Surgical Complications
8.6.10 Aug 28, 2025: Esaote Group to Showcase Cardiac Innovation at ESC 2025 in Madrid
8.6.11 Jun 09, 2025: Microtech Announces the First U.S. Atrial Microsensor Implantations as Part of Its FIH Study
8.6.12 Jun 09, 2025: Phillips Medisize Launches Theravolt Medical Connectors To Support Next-Gen Device Integration, Connectivity and Performance
8.7 Strategy And Business Planning
8.7.1 Feb 17, 2026: McLaren Health Care Launches AI-Powered Cardiovascular Screening in Michigan
8.7.2 Feb 06, 2026: Mercedes Medical: Introducing Our Expanded Warehouse Network
8.7.3 Jan 20, 2026: Foxo Technologies Subsidiary, Big South Fork Medical Center, Expands Clinical Capabilities
8.7.4 Jul 17, 2025: Catalyst Medtech Announces Expansion of Strategic Partnership With Arineta
8.7.5 Jul 07, 2025: Lifeforce and Toku Announce Nationwide Partnership
9 Appendix
9.1 Research Methodology
9.1.1 Coverage
9.1.2 Secondary Research
9.1.3 Primary Research
9.1.4 Market Modeling and Forecasting
9.1.5 Company Share Analysis
9.1.6 Benchmarking
9.2 the Analyst Consulting
9.3 Contact Us
9.4 Disclaimer
List of Tables
Table 1: Cardiac Disease Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036
Table 2: Cardiac Disease Market, North America, Revenue ($m), USD Constant, 2024-2036
Table 3: Cardiac Disease Market, North America, Volume (Units), 2024-2036
Table 4: Cardiac Disease Market, North America, Volume (Units), 2024-2036
Table 5: Cardiac Disease Market, North America, Company Share by Revenue ($m), 2025
Table 6: Cardiac Disease Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 7: Cardiac Marker Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 8: Cardiac Disease Market, Canada, Volume (Units), 2024-2036
Table 9: Cardiac Marker Tests Market, Canada, Volume (Units), 2024-2036
Table 10: Cardiac Disease Market, Canada, Average Price ($), 2024-2036
Table 11: Cardiac Disease Market, Canada, Company Share by Revenue ($m), USD Constant, 2025
Table 12: Cardiac Disease Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 13: Cardiac Marker Tests Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 14: Cardiac Disease Market, Mexico, Volume (Units), 2024-2036
Table 15: Cardiac Marker Tests Market, Mexico, Volume (Units), 2024-2036
Table 16: Cardiac Disease Market, Mexico, Average Price ($), 2024-2036
Table 17: Cardiac Disease Market, Mexico, Company Share by Revenue ($m), USD Constant, 2025
Table 18: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 19: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 20: Cardiac Disease Market, United States, Volume (Units), 2024-2036
Table 21: Cardiac Marker Tests Market, United States, Volume (Units), 2024-2036
Table 22: Cardiac Disease Market, United States, Average Price ($), 2024-2036
Table 23: Cardiac Disease Market, United States, Company Share by Revenue ($m), USD Constant, 2025
Table 24: Cardiac Disease Market Pipeline Products
Table 25: Cardiac Disease - Pipeline Products by Stage of Development
Table 26: Cardiac Disease Companies - Pipeline Products by Stage of Development
Table 27: Cardiac Disease - Pipeline Products by Segment
Table 28: Cardiac Disease - Pipeline Products by Territory
Table 29: Cardiac Disease - Pipeline Products by Regulatory Path
Table 30: Cardiac Disease - Pipeline Products by Estimated Approval Date
Table 31: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Cardiac Disease Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036
Figure 2: Cardiac Disease Market, North America, Revenue ($m), USD Constant, 2024-2036
Figure 3: Cardiac Disease Market, North America, Volume (Units), 2024-2036
Figure 4: Cardiac Disease Market, North America, Volume (Units), 2024-2036
Figure 5: Cardiac Disease Market, North America, Company Share (%), 2025
Figure 6: Cardiac Disease Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 7: Cardiac Marker Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 8: Cardiac Disease Market, Canada, Volume (Units), 2024-2036
Figure 9: Cardiac Marker Tests Market, Canada, Volume (Units), 2024-2036
Figure 10: Cardiac Disease Market, Canada, Company Share (%), 2025
Figure 11: Cardiac Disease Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 12: Cardiac Marker Tests Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 13: Cardiac Disease Market, Mexico, Volume (Units), 2024-2036
Figure 14: Cardiac Marker Tests Market, Mexico, Volume (Units), 2024-2036
Figure 15: Cardiac Disease Market, Mexico, Company Share (%), 2025
Figure 16: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 17: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 18: Cardiac Disease Market, United States, Volume (Units), 2024-2036
Figure 19: Cardiac Marker Tests Market, United States, Volume (Units), 2024-2036
Figure 20: Cardiac Disease Market, United States, Company Share (%), 2025
Figure 21: Cardiac Disease - Pipeline Products by Stage of Development
Figure 22: Cardiac Disease - Pipeline Products by Segment
Figure 23: Cardiac Disease - Pipeline Products by Territory
Figure 24: Cardiac Disease - Pipeline Products by Regulatory Path
Figure 25: Cardiac Disease - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Beckman Coulter Inc
  • Quidel Corp
  • Siemens Healthineers AG
  • bioMerieux SA